A Key Milestone for Therapeutic Exosome Production

posted Jan 13, 2025 9:00am  by  NurExone Biologic Inc.
A developer of exosome-based therapies for regenerative medicine has acquired a master cell bank from a U.S. manufacturer. The Acquisition marks a major step in ensuring a stable and scalable supply chain for production of exosome-based therapies for clinical needs and eventual patient treatment ...read more